NEWS - Bournemouth, UK – 17th August 2015: Solentim has strengthened its global reach during 2015 with a network of distributors now well established across Asia. This has resulted in significant number of sales for their Cell Metric™ and Cell Metric™ CLD units at pharma and biotech companies in China, Japan, South Korea, Taiwan and India. Additionally, some of these territories have already closed sales with multiple customer accounts
Sales and Marketing Director, Dr Ian Taylor, commented, “This is very gratifying after all the work we have put in to identify, select and train the right distribution partners and we are delighted with the rapid sales successes.” Dr Taylor continued "We see this upward growth trend continuing based on what we’ve seen while attending a number of key conferences across Asia in 2015. Firstly, there is a desire by the drug approval and regulatory bodies of these countries to harmonise their requirements with the US FDA, including importantly for proof of clonality; and secondly the recent boom in biosimilars and biologics in Asia has led to a local skills shortage in cell line development and consequently an urgent need for expert tools to help them bridge this gap."
Dr Taylor concluded "We are also witnessing a progressive trend in Asia of customers moving away from previous approaches of picking colonies from semi-solid media and choosing instead single cell seeding techniques combined with confirmation of clonality by imaging. This trend repeats what we’ve seen previously in the more mature markets of North America and Europe."
To support this sales success, and to demonstrate the ongoing commitment to our customers and distributor partners, Solentim will shortly be announcing its 2016 schedule of conferences throughout Asia.
Further details of Solentim’s Distributor Network